Reducing risky alcohol use in people with HIV
Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)
This program offers a flexible counseling approach to help adults with HIV who drink too much alcohol in Zambia and Alabama.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11173873 on NIH RePORTER |
What this research studies
If you have HIV and drink alcohol in ways that harm your health, this program may offer clinic-based counseling sessions using a common-elements therapy called CETA. Participants at participating HIV clinics will be randomly assigned to receive the counseling or usual care, and researchers will track alcohol use, HIV treatment adherence, and viral outcomes over time. The team will also look at how mental health and other conditions might change the benefit and will examine costs and practical issues to bring this care to more clinics. The work is happening in rural and hard-to-reach HIV clinics in Zambia and in sites in Alabama.
Who could benefit from this research
Good fit: Adults (21+) living with HIV who report unhealthy alcohol use and receive care at participating HIV clinics in Zambia or Alabama are the intended candidates.
Not a fit: People without unhealthy alcohol use, children, or those who do not receive care at the participating clinics are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the approach could lower unhealthy drinking and help people with HIV stay on treatment and achieve better viral control.
How similar studies have performed: Related transdiagnostic therapies have shown promise for mental health and substance use in low-resource settings, although integrating alcohol treatment into routine HIV care is still fairly new.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Cropsey, Karen L — University of Alabama at Birmingham
- Study coordinator: Cropsey, Karen L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.